hsa-miR-1184: Hsa-mir-1184 is a microRNA that has been identified in various studies as potentially playing a role in different diseases and biological processes [PMC5902673]. It has been found to be one of the microRNAs that may interact with GAPLINC, a long non-coding RNA [PMC5902673]. In one study, hsa-mir-1184 was selected as one of the superior candidates based on comprehensive assessments and was found to be highly related to GAPLINC [PMC5902673]. Hsa-mir-1184 has also been found to have deregulated expression in prostatic cancer [PMC5452331]. In addition, it has been identified as one of the miRNAs that may be involved in different diseases such as sepsis, inflammatory bowel disease, rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes [PMC9259025]. Furthermore, hsa-mir-1184 has been shown to have functional synergistic relationships with other miRNAs such as hsa-miR-1207-5p and hsa-miR-24 [PMC5228663]. It is also worth noting that hsa-mir-1184 shares target genes with other miRNAs such as hsa-miR-24 and may play a role in the development of certain diseases like pancreatic cancer and breast tumor metastasis [PMC5228663].